Nigeria’s African Centre Of Excellence For Genomics Of Infectious Diseases Develops COVID-19 Medicine

 Nigeria’s African Centre Of Excellence For Genomics Of Infectious Diseases Develops COVID-19 Medicine

The first African and Nigerian Vaccine on COVID-19 has been developed by African Centre of Excellence for Genomics of Infectious Diseases, Redeemer’s University, Ede, Nigeria.

A Professor of Molecular Biology and Director at the Centre, Prof. Christian Happi disclosed this on Monday, February 8, 2021, while featuring on BCOS TV breakfast program, ‘AM120’.

Prof. Happi said the locally produced vaccine had been tested in animals with 95 per cent success recorded.

The molecular Expert who stated that the vaccine was developed based on the COVID-19 variants circulating in Nigeria and Africa at large, added that inadequate funding is preventing the vaccine from undergoing human trial.

According to him, the vaccine can be stored under room temperature in Africa and thus does not required excessive cold chain for storage .

He, therefore, called on Governments in Nigeria and Africa, as well as the Private sector to support this laudable initiative that would place Nigeria and entire Africa in a respectable position among the world’s inventors and scientists .

Speaking further on the programme, Prof. Happi explained that a Nigerian variant of the pandemic has been detected in the country, alongside about 55th other variants circulating in the world..

The molecular Biologist enjoined Nigerians to religiously abide with the non-pharmaceutical protocols against COVID-19 as the vaccines now in the market can only guarantee immunity for just six months.

TINU

Related post

Leave a Reply

%d bloggers like this: